China: MicroTech Medical prices HK$1.94bn IPO

HKEX Connect Hall

MicroTech Medical (Hangzhou), a healthcare company focused on diabetes management, has priced a HK$1.94bn (US$249m) Hong Kong IPO at HK$30.50 per share, just short of the maximum marketed price of HK$31.15 range., according to IFR quoting a source near to the deal. Joint sponsors are CICC and Goldman Sachs. They were joined by Citic Securities as…

You must be a HMI Subscriber to view this content.

Subscribe Now »